R-Pharm Overseas, Inc.
๐บ๐ธUnited States
Efficacy and Safety of RPH-104 Treatment in Patients With Recurrent Pericarditis
- First Posted Date
- 2021-11-04
- Last Posted Date
- 2024-11-15
- Lead Sponsor
- R-Pharm Overseas, Inc.
- Target Recruit Count
- 80
- Registration Number
- NCT05107934
- Locations
- ๐บ๐ธ
Virginia Commonwealth University, Richmond, Virginia, United States
Study to Evaluate the Effect on Parameters of Systemic Inflammation and Disease Outcomes and Safety of RPH-104 in Subjects With Acute ST-elevation Myocardial Infarction
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2020-07-09
- Last Posted Date
- 2024-06-24
- Lead Sponsor
- R-Pharm Overseas, Inc.
- Target Recruit Count
- 102
- Registration Number
- NCT04463251
- Locations
- ๐ท๐บ
Ryazan State Medical University n.a. academician I.P. Pavlov on the basis of Regional Clinical cardiology Dispensary, Ryazan, Russian Federation
๐ท๐บState Institution of Healthcare in Moscow "City Clinical Hospital โ 51 Moscow Health Department", Moscow, Russian Federation
๐ท๐บSt. Petersburg State Budgetary Healthcare Institution "Saint Martyr Elizabeth City Hospital", St Petersburg, Russian Federation
Study of the Efficacy and Safety of RPH-104 in Adult Subjects With Schnitzler Syndrome
Phase 2
Withdrawn
- Conditions
- Interventions
- First Posted Date
- 2019-12-30
- Last Posted Date
- 2024-11-15
- Lead Sponsor
- R-Pharm Overseas, Inc.
- Target Recruit Count
- 14
- Registration Number
- NCT04213274
- Locations
- ๐บ๐ธ
Mayo Clinic, Rochester, Minnesota, United States
๐บ๐ธOregon Health & Science University, Portland, Oregon, United States
๐บ๐ธNational Jewish Health, Denver, Colorado, United States
ยฉ Copyright 2024. All Rights Reserved by MedPath